Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trialHarold Atkins, Mark S. Freedman, Marjorie A. Bowman et al.|The Lancet|2016Cited by 327
Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell TransplantationAdam Bryant, Christopher Bredeson, Isabelle Bence‐Bruckler et al.|JAMA Neurology|2016Cited by 103
A 15-Year Analysis of Early and Late Autologous Hematopoietic Stem Cell Transplant in Relapsed, Aggressive, Transformed, and Nontransformed Follicular LymphomaMitchell Sabloff, Lothar Huebsch, Harold Atkins et al.|Transplantation and Cellular Therapy|2007Cited by 57
Utility of Comorbidity Assessment in Predicting Transplantation-Related Toxicity Following Autologous Hematopoietic Stem Cell Transplantation for Multiple MyelomaLaura Labonté, David Allan, Tariq Iqbal et al.|Transplantation and Cellular Therapy|2008Cited by 55
Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomesSheryl McDiarmid, Lothar Huebsch, Brian Hutton et al.|Bone Marrow Transplantation|2009Cited by 51